Advertisement

Topics

Alzheon Publishes New Analyses Showing Clinical Benefit Of Tramiprosate In APOE4/4 Homozygous Patients With Mild Alzheimer???s Disease; Clinical Effects Suggest Disease Modification And Align With Beta Amyloid Oligomer Formation

20:00 EDT 21 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Alzheon Publishes New Analyses Showing Clinical Benefit Of Tramiprosate In APOE4/4 Homozygous Patients With Mild Alzheimer???s Disease; Clinical Effects Suggest Disease Modification And Align With Beta Amyloid Oligomer Formation

NEXT ARTICLE

More From BioPortfolio on "Alzheon Publishes New Analyses Showing Clinical Benefit Of Tramiprosate In APOE4/4 Homozygous Patients With Mild Alzheimer???s Disease; Clinical Effects Suggest Disease Modification And Align With Beta Amyloid Oligomer Formation"

Advertisement
Quick Search
Advertisement
Advertisement